{"id":"W7117357242","doi":"10.1080/13696998.2025.2604971","title":"A real-world study evaluating drug tolerability and health care resource use with acalabrutinib vs ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma","year":2025,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cancer Care Ontario","funders":"AstraZeneca United States","keywords":"Ibrutinib; Tolerability; Drug; Health care; Lymphoma; Resource use","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001543086,0.0002151701,0.0003457125,0.0006196875,0.0003744958,0.0009049868,0.0003829326,0.0004797651,0.001680838],"category_scores_gemma":[0.004701399,0.0002153848,0.0006494376,0.001151985,0.0003775542,0.0006569523,0.0005397173,0.0005628196,0.0001786441],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001151822,"about_ca_system_score_gemma":0.0005494595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004547221,"about_ca_topic_score_gemma":0.005566825,"domain_scores_codex":[0.99821,0.0008089792,0.0002001446,0.0003368552,0.0002407649,0.0002033526],"domain_scores_gemma":[0.9953201,0.0009152844,0.002663524,0.0001497767,0.0003374539,0.0006138586],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001509522,0.0002986452,0.9957307,0.00003586541,0.0002860129,0.00006279987,0.0001058053,0.0000831653,0.00009145697,0.00002124789,0.0001548305,0.00162006],"study_design_scores_gemma":[0.0003639604,0.002714523,0.9945447,0.00002365368,0.0002018829,0.0002790003,0.0006648428,0.0007503934,0.00007835425,0.00003306852,0.0003338885,0.00001165524],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993566,0.0001968363,0.00002660876,0.00003106512,0.000003513111,0.0000170598,0.0002132062,9.74914e-7,0.0001542275],"genre_scores_gemma":[0.9995357,0.00006131559,0.00002998126,0.00003931611,0.00001051081,0.00001875566,0.000273411,6.695535e-7,0.00003036793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004547221,"threshold_uncertainty_score":0.009041488,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02686499075694019,"score_gpt":0.3300574816797413,"score_spread":0.3031924909228011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}